Fourteen reverse convertibles, mostly from UBS, one autocallable and two leveraged return notes make up the latest batch of structured products to be filed with the SEC
Goldman Sachs is offering a leveraged return note based on an extraordinary 20 US stocks. Friday's registration of structured products for the public issuance market was otherwise peppered with reve...
This webinar on September 17th looks at the challenges of GRC, key trends, motives for improvement, future investments, and obstacles that banks and other financial institutions face in trying to improve and integrate their risk management strategy
More Ubs articles
JP Morgan and HSBC have filed principal-protected notes with lengthy terms with the SEC, while UBS has registered three five-year autocallables linked to ETFs
UBS and Credit Suisse have both filed products based on the performance of Apple shares with the SEC. Half of the latest products registered with the regulator are leveraged return notes
Thirty-one structured products were registered with the US Securities and Exchange Commission on March 9, with UBS providing nine autocallables and reverse convertibles
A mass of new structured products registered in the US public market are dominated by HSBC and UBS, though Goldman Sachs stands out in terms of tenor with its five-year capital-protected note
Available to trade?
Reverse convertibles continue to dominate structured products registered with the US Securities and Exchange Commission, while ETF underlyings provide the most excitement for those eager to diversify
Barclays Bank has filed two structured products with the US Securities and Exchange Commission based on State Street industrial and technology exchange-traded funds
City of London Police investigating blocked trade
HSBC leads the Greenwich Associates survey rankings for retail structured product quality, while Barclays Capital has the best-known franchise among distributors and BNP Paribas retains top spot in ...
Playing it safe
Hard times for metals markets
In response to industry fears of a collateral crunch, regulators have revised the proposed rules on margining for uncleared over-the-counter (OTC) derivatives.You can find out more by downloading this white paper here.